LINC02591: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

Target Name: LINC02591

NCBI ID: G388692

LINC02591

Other Name(s): Uncharacterized LOC388692 | long intergenic non-protein coding RNA 2591 | LOC388692

LINC02591: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

LINC02591 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is derived from the long non-coding RNA (lnc) domain and has been shown to play a role in various cellular processes, including cell adhesion , migration, and transcriptional regulation.

One of the key features of LINC02591 is its ability to interact with the protein kinase PDGFR. This interaction allows LINC02591 to regulate the activity of PDGFR, which is a key regulator of cell proliferation and survival. Additionally, LINC02591 has been shown to play a role in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and function.

Another feature of LINC02591 is its ability to interact with the transcription factor, NF-kappa-B. This interaction allows LINC02591 to regulate the activity of NF-kappa-B, which is a key regulator of inflammation and stress responses.

In addition to its role in cell signaling, LINC02591 has also been shown to play a role in the regulation of cellular processes such as cell cycle progression, apoptosis, and cellular senescence.

Given its involvement in a wide range of cellular processes, LINC02591 is a promising candidate for drug targeting or biomarker development. Studies have shown that LINC02591 can be effectively targeted with small molecules, antibodies, or RNA-based therapeutics.

In addition to its potential as a drug target, LINC02591 has also been shown to be a potential biomarker for a variety of diseases. For example, LINC02591 has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer . Additionally, LINC02591 has been shown to be involved in the regulation of cellular processes that are implicated in the development of certain neurological disorders, such as Alzheimer's disease and Parkinson's disease.

Overall, LINC02591 is a fascinating molecule that has the potential to be a drug target or biomarker. Further studies are needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 2591

The "LINC02591 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02591 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets